Biomind Labs Inc (BMND) - Total Liabilities

Latest as of September 2025: CA$1.62 Million CAD ≈ $1.17 Million USD

Based on the latest financial reports, Biomind Labs Inc (BMND) has total liabilities worth CA$1.62 Million CAD (≈ $1.17 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Biomind Labs Inc (BMND) cash flow conversion to assess how effectively this company generates cash.

Biomind Labs Inc - Total Liabilities Trend (2021–2024)

This chart illustrates how Biomind Labs Inc's total liabilities have evolved over time, based on quarterly financial data. See Biomind Labs Inc shareholders equity for net asset value and shareholders' equity analysis.

Biomind Labs Inc Competitors by Total Liabilities

The table below lists competitors of Biomind Labs Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Augros Cosmetic Packaging SA PA:AUGR	France	€12.18 Million
Perrot Duval Holding SA SW:PEDU	Switzerland	CHF5.52 Million
Kanger International Bhd KLSE:0170	Malaysia	RM36.56 Million
Biotricity Inc NASDAQ:BTCY	USA	$37.98 Million
Aeris Environmental Ltd AU:AEI	Australia	AU$7.45 Million
Total Telcom Inc V:TTZ	Canada	CA$573.41K
Torr Metals Inc V:TMET	Canada	CA$1.80 Million
Curative Biotechnology Inc NYSE MKT:CUBT	USA	$7.28 Million

Liability Composition Analysis (2021–2024)

This chart breaks down Biomind Labs Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Biomind Labs Inc stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.04	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	28.03	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biomind Labs Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biomind Labs Inc (2021–2024)

The table below shows the annual total liabilities of Biomind Labs Inc from 2021 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$1.34 Million ≈ $970.31K	-10.95%
2023-12-31	CA$1.51 Million ≈ $1.09 Million	+347.35%
2022-12-31	CA$336.72K ≈ $243.58K	+0.53%
2021-12-31	CA$334.95K ≈ $242.30K	--

About Biomind Labs Inc

NEO:BMND Canada Biotechnology

Market Cap

$10.38 Million

CA$14.35 Million CAD

Market Cap Rank

#27686 Global

#1219 in Canada

Share Price

CA$0.19

Change (1 day)

+68.18%

52-Week Range

CA$0.01 - CA$0.35

All Time High

CA$1.90